6317-81-3 Usage
General Description
The chemical compound "(2E)-1-(4-phenoxyphenyl)-3-phenylprop-2-en-1-one" is an organic compound with the molecular formula C21H16O2. It is a ketone with a phenyl group and a phenoxy group attached to a propenone backbone. (2E)-1-(4-phenoxyphenyl)-3-phenylprop-2-en-1-one has potential applications in pharmaceuticals, agrochemicals, and material science due to its unique structure and properties. It may be used as a building block in the synthesis of more complex organic molecules and has the potential for biological activity and medicinal applications. The compound's chemical structure and potential reactivity make it an interesting target for further research and development in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 6317-81-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,1 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6317-81:
(6*6)+(5*3)+(4*1)+(3*7)+(2*8)+(1*1)=93
93 % 10 = 3
So 6317-81-3 is a valid CAS Registry Number.
6317-81-3Relevant articles and documents
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation
Fioravanti, Rossella,Desideri, Nicoletta,Carta, Antonio,Atzori, Elena Maria,Delogu, Ilenia,Collu, Gabriella,Loddo, Roberta
, p. 15 - 25 (2017/10/16)
By the antiviral screening of an in house library of pyrazoline compounds, 4-(3-(4-phenoxyphenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide (5a) was identified as a promising hit compound for the development of anti- Yellow Fever Virus (YFV)
ALLOSTERIC PROTEIN KINASE MODULATORS
-
Page/Page column 51, (2012/03/10)
The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.